Vivani Medical (VANI) EBITDA Margin Growth (3y) (2017 - 2022)
Powered by 
Analysis
Vivani Medical (VANI) EBITDA Margin Growth (3y) (2017 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 640.34 Bn | 619.59 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 445.94 Bn | 439.37 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 356.80 Bn | 349.66 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 269.15 Bn | 261.46 Bn | 11.24 Bn | 842.00 |
| 5 | Pfizer | 156.49 Bn | 144.80 Bn | 10.94 Bn | 214.00 |
| 6 | Sanofi | 52.18 Bn | 44.80 Bn | 10.79 Bn | -963.00 |
| 7 | Revolution Medicines | 43.29 Bn | 43.29 Bn | - | - |
| 8 | Incyte | 24.98 Bn | 20.44 Bn | 1.57 Bn | 2,139.00 |
| 9 | United Therapeutics | 21.33 Bn | 18.67 Bn | 683.80 Mn | -1,031.00 |
| 10 | Vivani Medical | 110.60 Mn | 90.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 62,177.00 |
| Sep 30, 2021 | -21.74 Mn |
| Mar 31, 2021 | 82,323.00 |
| Sep 30, 2020 | 31,907.00 |
| Mar 31, 2020 | 19,226.00 |
| Dec 31, 2019 | -18,284.00 |
| Sep 30, 2019 | -89,394.00 |
| Jun 30, 2019 | 16,192.00 |
| Mar 31, 2019 | -31,316.00 |
| Dec 31, 2018 | -27,050.00 |
| Sep 30, 2018 | -17,114.00 |
| Sep 30, 2017 | 50,774.00 |